Serious adverse event
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
A serious adverse event (SAE) in human drug trials are defined as any untoward medical occurrence that at any dose results in
- death,
- is life-threatening
- requires inpatient hospitalization or prolongation of existing hospitalization
- results in persistent or significant disability/incapacity, or
- is a congenital anomaly/birth defect.[1]
The term "life-threatening" in the definition of "serious" refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.[1] Adverse events are further defined as “Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.”[1]
Research
Investigators in human clinical trials are obligated to report these events in clinical study reports [2] . Research suggests that these events are often inadequately reported in publicly available reports.[3] Because of the lack of these data and uncertainty about methods for synthesising them, individuals conducting systematic reviews and meta-analysis of therapeutic interventions often unknowingly overemphasise health benefit.[4] In order to balance the overemphasis on benefit, scholars have called for more complete reporting of harm from clinical trials.[5]
Related Terms
Serious adverse effects , serious adverse reactions, or suspected unexpected serious adverse reactions (SUSAR) are serious adverse events judged to be related to therapy. A SUSAR is to be reported to the regulatory authority by using the CIOMS form:
- The event must be a SAE.
- There must be a certain degree of probability that the event is an adverse reaction on the administered drug.
- The adverse reaction must be unexpected, that is to say, not foreseen in the SPC text (Summary of Product Characteristics (for an authorised medicinal product)) or the Investigator’s Brochure (for an unauthorised medicinal product).
Footnotes
- ↑ 1.0 1.1 1.2 Expert Working Group (Efficacy) of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). (August 25, 2007). Guideline for Industry - Clinical safety data management: definitions and standards for expedited reporting. (PDF). FDA Center for Drug Evaluation and Research.}
- ↑ Expert working group (efficacy) of the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use. (August 25, 2007). [http://www.fda.gov/cder/guidance/iche3.pdf Guideline for Industry Structure and Content of Clinical Study Reports.] (PDF). FDA Center for Drug Evaluation and Research.}
- ↑ Ioannidis JP, Lau J. (2001). "Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.". JAMA 285(4): 437–43. PMID 11242428.
- ↑ Chou R, Helfand M. (2005). "Challenges in systematic reviews that assess treatment harms.". Ann Intern Med 142(12 Pt 2): 1090–0. PMID 15968034.
- ↑ Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D; CONSORT Group. (2004). "Better reporting of harms in randomized trials: an extension of the CONSORT statement.". Ann Intern Med 141(10): 781–8. PMID 15545678.
See also
- Clinical trial
- Good clinical practice (GCP)
- Data Monitoring Committees
- Pharmacovigilance
- EudraVigilance (European Union)
- Directive 2001/20/EC (European Union)
- TGN1412
External links
- What Is A Serious Adverse Event? (MedWatch)
- FDA Website
- ClinicalTrials.gov from US National Library of Medicine
- ICH Website
- PharmaSchool JargonBuster Clinical Trial Terminology Dictionaryde:Serious Adverse Event
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
